Opportunity
RFI Lupus Research Program (LRP) Public
Response due
November 16, 2026
- Agency
- Defense Health Agency
- Estimated value
- Not stated
The Congressionally Directed Medical Research Programs (CDMRP) seeks feedback to inform potential future Lupus Research Program (LRP) focus areas and associated research funding opportunities. Although fiscal year 2027 (FY27) funds have not been appropriated , the LRP is requesting this information to support program planning processes . The CDMRP wants to hear from all audiences, interested parties, and individuals from academia, industry, community and non-profit organizations, scientific and professional organizations, federal agencies, and the public. This RFI is for information and planning purposes only and should not be construed as a solicitation or an obligation on the part of the LRP or the Department of War. BACKGROUND: The CDMRP represents a unique partnership between the U.S. Congress, the military, and the public to fund innovative and impactful medical research in targeted program areas. The CDMRP LRP’s vision is to cure lupus through partnership of scientists, clinicians and persons affected by lupus. The LRP’s mission is to fund research to understand, prevent, and diagnose lupus and to improve treatments and quality of life of patients, including Service Members and their Families, Veterans and the general public. Appropriations for the LRP from FY17-24 and FY26 totaled $75 million. As of October 2026, FY27 funds for the LRP have not been appropriated. If appropriated, the CDMRP will utilize its two-tier review process https://cdmrp.health.mil/about/2tierRevProcess) to efficiently manage the LRP. Additional information about the LRP can be found here: https://cdmrp.health.mil/lrp/ RESPONSE INSTRUCTIONS: Please provide responses to this RFI by clicking on the following link: https://www.surveymonkey.com/r/FY27-LRP-RFI
Key dates
- Posted
- October 15, 2026
- Response due
- November 16, 2026
Who is this buyer
Organization
Buying history
- Records688 total
- Opportunities / awards15 / 519
- Value range$0 – $74,497,231
- ActiveApril 13, 2026 – October 18, 2026
What they buy
- Clinical (650)
- Administrative (34)
- Insurance (4)
Set-asides used
- No Set aside used (98)
- Small Business Set Aside - Total (25)
- 8(a) Set-Aside (FAR 19.8) (3)
- WOSB Program Set-Aside (FAR 19.15) (2)
Who holds their work today
- DILLIGAS CORP30 wins · $149,641,771 · last October 1, 2025
- MAGNIFICUS CORPORATION34 wins · $134,018,385 · last October 1, 2024
- THE ARORA GROUP, INC.7 wins · $121,707,391 · last October 1, 2024
- ENTERPRISE RESOURCE PLANNING INTERNATIONAL, LLC32 wins · $116,974,988 · last April 1, 2025
- MATRIX PROVIDERS INC.17 wins · $90,734,436 · last October 1, 2025
Also open from this buyer
- Instrument Sterilization Services for Guthrie Army Health Clinic, Fort Drum, NYDue October 23, 2026 · Clinical
- Zeiss Meditec Ophthalmology Equipment MaintenanceDue October 29, 2026 · Clinical
- Notice of Intent DNA SynthesizerDue November 2, 2026 · Clinical
- Premier Shockwave Notice of IntentDue October 28, 2026 · Clinical
View source document →
Source link on sam.gov.
Source record
- Buyer type
- Federal
- Jurisdiction
- Federal (US)
- Category
- Clinical
- Set-aside
- Not stated
- NAICS
- 541714
- PSC
- Not stated